Windlas Biotech (BOM:543329) Ending Cash Position : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech Ending Cash Position?

Windlas Biotech's Ending Cash Position for the quarter that ended in Dec. 2024 was ₹0 Mil.

Windlas Biotech's annual Ending Cash Position increased from Mar. 2022 (₹6 Mil) to Mar. 2023 (₹37 Mil) and increased from Mar. 2023 (₹37 Mil) to Mar. 2024 (₹53 Mil).

Windlas Biotech Ending Cash Position Historical Data

The historical data trend for Windlas Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech Ending Cash Position Chart

Windlas Biotech Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

180.78

159.30

5.70

36.86

52.88

Windlas Biotech Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Windlas Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Windlas Biotech's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	36.86	+	16.02
	=	53

Windlas Biotech's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Windlas Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Windlas Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Windlas Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (BOM:543329) » Definitions » Ending Cash Position

Traded in Other Exchanges

WINDLAS:India

Address

Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001

Website

https://www.windlas.com

Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech Headlines

No Headlines